For research use only. Not for therapeutic Use.
Sunitinib N-Oxide-d10 is a deuterated form of Sunitinib N-Oxide, featuring ten deuterium atoms. This compound is used in pharmaceutical research to study the metabolism, pharmacokinetics, and interactions of sunitinib, an anti-cancer drug. The deuterium labeling enhances the precision of analytical techniques such as NMR and mass spectrometry, allowing for detailed tracking of the compound’s behavior in biological systems. Sunitinib N-Oxide-d10 aids in understanding the metabolic pathways and stability of sunitinib, optimizing drug formulations, and improving therapeutic strategies for cancer treatment by providing accurate data on drug dynamics and interactions.
Catalog Number | R021820 |
CAS Number | NA |
Synonyms | N-[2-(Diethyloxidoamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide-d10; 5-(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethyl-N-oxoa |
Molecular Formula | C₂₂H₁₇D₁₀FN₄O₃ |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | 1,1,2,2,2-pentadeuterio-N-[2-[[5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carbonyl]amino]ethyl]-N-(1,1,2,2,2-pentadeuterioethyl)ethanamine oxide |
InChI | InChI=1S/C22H27FN4O3/c1-5-27(30,6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-/i1D3,2D3,5D2,6D2 |
InChIKey | DNCVCKYIYMUMFC-BLSNYXODSA-N |
SMILES | [2H]C([2H])([2H])C([2H])([2H])[N+](CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C)(C([2H])([2H])C([2H])([2H])[2H])[O-] |